Alteplase at 0.6 mg/kg for acute ischemic stroke within 3 hours of onset: Japan Alteplase Clinical Trial (J-ACT). [electronic resource]
Producer: 20060718Description: 1810-5 p. digitalISSN:- 1524-4628
- Aged
- Aged, 80 and over
- Brain Ischemia -- drug therapy
- Cerebral Hemorrhage -- chemically induced
- Cohort Studies
- Dose-Response Relationship, Drug
- Drug Administration Schedule
- Europe -- epidemiology
- Female
- Fibrinolytic Agents -- administration & dosage
- Humans
- Infusions, Intravenous
- Injections, Intravenous
- Intracranial Embolism -- drug therapy
- Japan -- epidemiology
- Male
- Middle Aged
- North America -- epidemiology
- Prospective Studies
- Thrombolytic Therapy -- adverse effects
- Time Factors
- Tissue Plasminogen Activator -- administration & dosage
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.